AMM 346: Migraine Relief Breakthrough: Maine Comprehensive Pain Management’s with Botox
February 04, 2025
This episode highlights a recent development in migraine treatment from Maine Comprehensive Pain Management in Scarborough, Maine. The clinic reported a 95% positive response rate using a modified version of the FDA-approved PREEMPT injection protocol with Botox. By making slight adjustments to injection sites, significant improvements were achieved in migraine management, offering hope for those suffering from chronic migraines.
Quick Takes
- Maine Comprehensive Pain Management in Scarborough, Maine has made an exciting development in migraine treatment using Botox (OnabotulinumtoxinA).
- Their modified injection protocol based on the FDA-approved PREEMPT method led to a 95% positive response rate in patients, with some experiencing a 50% improvement in migraines.
- The revised protocol includes small adjustments in injection sites in the neck and head muscle groups, optimizing the therapy’s effectiveness for chronic migraine management.
Episode Transcript
Today’s update in aesthetic medicine comes from Scarborough, Maine, where Maine Comprehensive Pain Management has highlighted an exciting development in migraine treatment. Chronic migraines, which significantly impair quality of life, may have found an effective treatment with Botox, scientifically known as OnabotulinumtoxinA. This treatment follows the PREEMPT injection protocol, a method approved by the FDA back in 2010.
In their recent study, Maine Comprehensive Pain Management introduced a modified version of this protocol, demonstrating remarkable success. Their strategy resulted in a stunning 95% positive response rate among patients, with some experiencing at least a 50% improvement in their migraines. This revised approach includes small adjustments to injection sites at key muscle groups in the neck and head, which appears to maximize the therapy’s effectiveness.
Such advances promise improved management for those suffering from chronic migraine. February 4th, and with breakthroughs like these, the future for headache relief is bright. Stay hopeful and informed!